Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease
- 1 June 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (7), 2030-2037
- https://doi.org/10.1016/s0735-1097(99)00128-x
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Guide to Primary Prevention of Cardiovascular DiseasesCirculation, 1997
- Estrogen replacement therapyThe American Journal of Medicine, 1996
- Prospective study of exogenous hormones and risk of pulmonary embolism in womenThe Lancet, 1996
- How Do We Explain the Clinical Benefits of Estrogen?Circulation, 1995
- 17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart DiseaseCirculation, 1995
- The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary VasomotionNew England Journal of Medicine, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal WomenJAMA, 1995
- Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapyThe American Journal of Cardiology, 1994